Sophie Piperno‐Neumann

Université Paris Sciences et Lettres — France

Medicine · Health Sciences

69h-index21.3kcitations557works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(222), Ocular Oncology and Treatments(218), Immunotherapy and Immune Responses(91), Vascular Tumors and Angiosarcomas(57), Cancer Genomics and Diagnostics(55)

Publications556 total

UVEAL MELANOMA: CHANGING PARADIGMS OF TREATMENT
Ocular Oncology and Pathology·2025
Table 3 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Table 2 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Supplementary Data 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Table 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Figure 2 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Figure 3 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Figure 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
2025Open Access
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real‐life national setting over a decade
International Journal of Cancer·2025
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database
European Journal of Cancer·2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
Clinical Cancer Research·2025Open Access
LBA58 PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM)
Annals of Oncology·2025
1656P Clinical and molecular outcomes of tebentafusp in metastatic uveal melanoma (MUM): A retrospective cohort of 168 patients
Annals of Oncology·2025
Clinical presentation, management and outcome of 11132 patients with liposarcoma: a population-based study from the NETSARC+ registry
The Lancet Regional Health - Europe·2025· 2 citedOpen Access
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review
British Journal of Cancer·2025Open Access
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres
European Journal of Cancer·2025· 1 citedOpen Access
Management of metastatic uveal melanoma: French expert consensus guidelines
Bulletin du Cancer·2025· 2 citedOpen Access
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum
JAMA Ophthalmology·2025· 2 cited
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas.
Journal of Clinical Oncology·2025· 3 cited
Abstract 4906: A prospective analysis identified mismatch repair genes as predisposing for uveal melanoma
Cancer Research·2025
page 1 of 28Next →

Frequent Co-authors

Jean‐Yves Blay(30), Emmanuelle Bompas(20), Nicolas Penel(19), Antoîne Italiano(17), Nicolás Isambert(15), Sylvie Bonvalot(14), Christine Chevreau(13), Piotr Rutkowski(12), Axel Le Cesne(11), Axel Le Cesne(11), Thomas Brodowicz(10), Javier Martín‐Broto(10), Hans Gelderblom(10), Giovanni Grignani(10), Alessandro Gronchi(10), Bernd Kasper(10), Silvia Stacchiotti(10), Olivier Mir(10), Paolo G. Casali(9), Sebastian Bauer(9)